An Immunohistochemical Comparison of H3K27me2 and H3K27me3 Expression with Emphasis on Malignant Peripheral Nerve Sheath Tumors (MPNST), Diffuse Midline Glioma and Melanoma

被引：0
|
作者：
McCann, Brooke [1 ]
Roden, Anja [1 ]
Giannini, Caterina [1 ]
Folpe, Andrew [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
846
引用
收藏
页码：827 / 827
页数：1
相关论文
共 50 条
  • [21] Loss of H3K27me3 in meningiomas
    Nassiri, Farshad
    Wang, Justin Z.
    Singh, Olivia
    Karimi, Shirin
    Dalcourt, Tatyana
    Ijad, Nazanin
    Pirouzmand, Neda
    Ng, Ho-Keung
    Saladino, Andrea
    Pollo, Bianca
    Dimeco, Francesco
    Yip, Stephen
    Gao, Andrew
    Aldape, Kenneth D.
    Zadeh, Gelareh
    NEURO-ONCOLOGY, 2021, 23 (08) : 1282 - 1291
  • [22] H3K27me3 in glomerular disease
    Susan J. Allison
    Nature Reviews Nephrology, 2018, 14 : 143 - 143
  • [23] Loss of HP1 causes depletion of H3K27me3 from facultative heterochromatin and gain of H3K27me2 at constitutive heterochromatin
    Jamieson, Kirsty
    Wiles, Elizabeth T.
    McNaught, Kevin J.
    Sidoli, Simone
    Leggett, Neena
    Shao, Yanchun
    Garcia, Benjamin A.
    Selker, Eric U.
    GENOME RESEARCH, 2016, 26 (01) : 97 - 107
  • [24] Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors
    Otsuka, Hiroshi
    Kohashi, Kenichi
    Yoshimoto, Masato
    Ishihara, Shin
    Toda, Yu
    Yamada, Yuichi
    Yamamoto, Hidetaka
    Nakashima, Yasuharu
    Oda, Yoshinao
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (03) : 417 - 425
  • [25] Epigenetic Modifications in Cutaneous Malignant Melanoma: EZH2, H3K4me2, and H3K27me3 Immunohistochemical Expression is Enhanced at the Invasion Front of the Tumor
    Kampilafkos, Panagiotis
    Melachrinou, Maria
    Kefalopoulou, Zinovia
    Lakoumentas, John
    Sotiropoulou-Bonikou, Georgia
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2015, 37 (02) : 138 - 144
  • [26] Dynamic H3K27me3 reprogramming during glioma development
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 33 - 33
  • [27] Evaluation of H3K27me3 and EZH2 in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant GBM
    Venneti, Sriram
    Garimella, Mihir
    Sullivan, Lisa
    Martinez, Daniel
    Huse, Jason
    Heguy, Adriana
    Santi, Mariarita
    Thompson, Craig
    Judkins, Alexander
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (06): : 574 - 574
  • [28] Evaluation of H3K27me3 and EZH2 in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant GBM
    Venneti, Sriram
    Garimella, Mihir
    Sullivan, Lisa
    Martinez, Daniel
    Huse, Jason
    Heguy, Adriana
    Santi, Mariarita
    Thompson, Craig
    Thompson, Craig
    Alexander, Judkins
    CANCER RESEARCH, 2013, 73
  • [29] H3K27me3expression and methylation status in histological variants of malignant peripheral nerve sheath tumours
    Lyskjaer, Iben
    Lindsay, Daniel
    Tirabosco, Roberto
    Steele, Christopher D.
    Lombard, Patrick
    Strobl, Anna-Christina
    Rocha, Ana M.
    Davies, Christopher
    Ye, Hongtao
    Bekers, Elise
    Ingruber, Julia
    Lechner, Matt
    Amary, Fernanda
    Pillay, Nischalan
    Flanagan, Adrienne M.
    JOURNAL OF PATHOLOGY, 2020, 252 (02): : 151 - 164
  • [30] EVALUATION OF H3K27ME3 AND EZH2 IN PEDIATRIC GLIAL AND GLIONEURONAL TUMORS SHOWS DECREASED H3K27me3 IN H3F3A K27M MUTANT GBM
    Venneti, Sriram
    Garimella, Mihir
    Sullivan, Lisa
    Martinez, Daniel
    Huse, Jason
    Heguy, Adriana
    Santi, Mariarita
    Thompson, Craig
    Judkins, Alexander
    NEURO-ONCOLOGY, 2013, 15 : 163 - 163
12345